| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |